CBER status on reform initiatives: industry reactions and comments.
Page
M
M
D001688:Biological Products / Q000592:standards*; D001709:Biotechnology / Q000592:standards*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004348:Drug Labeling / Q000592:standards; D018166:Health Care Reform; D006801:Humans; D007221:Industry; D014481:United States; D014486:United States Food and Drug Administration
D001688:Biological Products